Cafcit side effects by duration, gender and age - a phase IV clinical study of FDA data

< 1 month:

1. Apnoea (suspension of external breathing)
2. Retinal detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue)

1 - 6 months:

1. Tachypnoea (condition of rapid breathing over 20 per minute)

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

1. Blood in stool
2. Drug administration error
3. Drug level below therapeutic
4. General physical health deterioration (weak health status)
5. Haematochezia (passage of stools containing blood)
6. Oxygen saturation decreased
7. Post lumbar puncture syndrome
8. Drug maladministration
9. Anaemia (lack of blood)
10. Necrotising enterocolitis (life threatening infection of intestine)

female:

1. Drug administration error
2. Drug maladministration
3. Anaemia (lack of blood)
4. Akinesia (loss of control of voluntary muscle movements)
5. Apnoea (suspension of external breathing)
6. Blood creatine phosphokinase increased

male:

1. Necrotising enterocolitis (life threatening infection of intestine)
2. Abdominal distension
3. Drug level below therapeutic
4. General physical health deterioration (weak health status)
5. Oxygen saturation decreased
6. Tachypnoea (condition of rapid breathing over 20 per minute)

0-1:

1. Apnoea (suspension of external breathing)
2. Drug administration error
3. Drug maladministration
4. General physical health deterioration (weak health status)
5. Tachypnoea (condition of rapid breathing over 20 per minute)

2-9:

n/a

10-19:

1. Anaemia (lack of blood)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

n/a